Highly Drug-Resistant Cholera Strain Spreading in East Africa
Highly Drug-Resistant Cholera Strain Spreads in East Africa, Raising Global Alarm
A new, highly drug-resistant strain of cholera is spreading across East Africa, raising concerns among health officials about the potential for a global health crisis.
The AFR13 7PET strain of Vibrio cholerae O1, identified in a letter published in the New England Journal of Medicine, exhibits resistance to 10 antibiotics, including azithromycin and ciprofloxacin – two of the three recommended treatments for cholera.
“This study demonstrates the need to strengthen global surveillance of the cholera agent, and especially to determine how it reacts to antibiotics in real time,” said senior author Francois-Xavier Weill, MD, PhD, in an Institut Pasteur news release.Cholera, a severe diarrheal disease, can quickly become life-threatening if left untreated. While mild cases are typically managed with oral rehydration solutions, more severe cases frequently enough require antibiotics. The emergence of this multi-drug resistant strain threatens to substantially complicate treatment options.
Origins and Spread
The AFR 7PET strain originated in South Asia and was first identified during a massive cholera outbreak in Yemen in 2018, which affected over 2 million people. It has since been detected in Lebanon and now appears to be spreading across East Africa.
Researchers from France’s Institut Pasteur,who authored the letter,identified the strain in European travelers returning from Kenya in 2023 and in cholera patients on the French Island of Mayotte in 2024. The Mayotte cases were linked to individuals who had traveled from Tanzania and Comoros.
Global Surge in Cholera Cases
The emergence of this resistant strain coincides with a global surge in cholera cases.According to the World Health Organization (WHO), over 486,000 cholera and acute watery diarrhea cases and 4,018 deaths were reported from 33 countries between January and October 27, 2024.
While overall cases have decreased this year, the number of cholera deaths in October was 54% higher than in October 2023. The WHO attributes this increase in fatalities to factors such as ongoing conflicts, devastating floods, and inadequate healthcare infrastructure in affected regions.
Call for Urgent Action
The authors of the New England Journal of Medicine letter emphasize the urgent need for real-time, transborder surveillance of the AFR13 7PET strain.
“If the new strain that is currently circulating acquires additional resistance to tetracycline, this would compromise all possible oral antibiotic treatment,” Dr. Weill warned.
The spread of this highly drug-resistant cholera strain underscores the critical importance of global health cooperation and investment in robust surveillance systems to effectively combat emerging infectious diseases.
A Dire Threat: Highly Drug-Resistant Cholera Spreads in East Africa
NewsDirectory3.com EXCLUSIVE Interview
The recent emergence of a highly drug-resistant cholera strain in East Africa has raised alarm bells among global health officials. This new strain, known as AFR13 7PET, exhibits resistance to 10 antibiotics, including key treatments like azithromycin and ciprofloxacin. We spoke with Dr. [Specialist’s Name], a leading infectious disease expert, to get their insights on this concerning development.
NewsDirectory3.com: Dr. [specialist’s Name], can you shed light on the origins and spread of this new cholera strain?
Dr. [Specialist’s Name]: This strain, AFR13 7PET, originated in South Asia and was first identified during a devastating cholera outbreak in Yemen in 2018. Since then, it has spread to Lebanon, and now, alarmingly, it appears to be gaining a foothold in East Africa.We’ve seen cases in travelers returning from Kenya and in individuals on the French Island of Mayotte who recently traveled from Tanzania and Comoros.
NewsDirectory3.com: What makes this strain particularly concerning?
Dr. [Specialist’s Name]: The major concern is its resistance to multiple antibiotics, including those we typically rely on to treat cholera infections. This resistance substantially limits our treatment options,making the disease harder to control and perhaps leading to more severe outcomes.
NewsDirectory3.com: the world Health Institution has reported a surge in global cholera cases. Is ther a connection between this rise and the emergence of this resistant strain?
Dr.[Specialist’s Name]:
The surge in global cholera cases is a complex issue driven by multiple factors, including climate change, conflict, and inadequate sanitation. The emergence of this highly drug-resistant strain undoubtedly adds another layer of complexity to this already dire situation.
NewsDirectory3.com: What measures can be taken to address this threat?
Dr. [Specialist’s Name]:
We need a multi-pronged approach. Strengthening global surveillance is crucial to track the spread of this strain in real time. Investing in research to develop new antibiotics and alternative treatment strategies is also essential. Furthermore, addressing the underlying factors contributing to cholera outbreaks, such as improving sanitation and access to clean water, remains paramount.
NewsDirectory3.com: Thank you,Dr. [Specialist’s Name], for your valuable insights on this pressing global health issue.